Table 1.
Distribution of miR-320 in gastric cancer according to clinicopathological characteristics
| Characteristics | Number of patients | miR-320 low expression | miR-320 high expression | P-value |
|---|---|---|---|---|
| Age, years | 0.8812 | |||
| <60 | 14 | 7 | 7 | |
| ≥60 | 19 | 10 | 9 | |
| Gender | 0.2006 | |||
| Male | 24 | 14 | 10 | |
| Female | 9 | 3 | 6 | |
| Differentiation | 0.6193 | |||
| Poor–moderate | 20 | 11 | 9 | |
| Well | 13 | 6 | 7 | |
| Tumor invasion (T) | 0.0488 | |||
| T1+T2 | 11 | 3 | 8 | |
| T3+T4 | 22 | 14 | 8 | |
| Lymph node metastasis | 0.3930 | |||
| Absent | 14 | 6 | 8 | |
| Present | 19 | 11 | 8 | |
| TNM stage | 0.0380 | |||
| I | 7 | 1 | 6 | |
| II | 9 | 4 | 5 | |
| III | 17 | 12 | 5 |
Abbreviation: tumor-node-metastasis.